Clin Asst Prof Amit Jain

About

Dr Amit Jain is a senior consultant in the Division of Medical Oncology at the National Cancer Centre Singapore. He has completed a PhD and wishes to embark on a career in translational research with a focus on immunotherapy for lung cancer.

Education and Training

• MBBS 
• MRCP (UK) 
• MMed 

Professional Appointments and Committee Memberships

• Senior Consultant, Department of Medical Oncology, National Cancer Centre 
• Singapore Singapore Medical Association, Member 
• Medical Society, National University of Singapore, Special Projects In-Charge 
• Medical Society, National University of Singapore, Committee Member
  

Awards

• Youth Investigators Award (Clinical Research) Finalist, Singapore General Hospital Annual Scientific Meeting 2013
  

Research Interests

• Mutations in Lung Adenocarcinoma and their clinical significance, including EGFR mutations.
  

Publications

• Sutiman N, Tan SW, Tan EH, Lim WT, Kanesvaran R, Ng QS, Jain A, Ang MK, Tan WL, Toh CK, Chowbay B. EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients. J Thorac Oncol. 2017 Mar;12(3):529-538. doi: 10.1016/j.jtho.2016.11.2225. Epub 2016 Nov 28. PMID: 27908825 
• Tan WL, Jain A, Takano A, Newell EW, Iyer NG, Lim WT, Tan EH, Zhai W, Hillmer AM, Tam WL, Tan DS. Lancet Oncol. 2016 Aug;17(8):e347-62. doi: 10.1016/S1470-2045(16)30123-1. Review. Novel therapeutic targets on the horizon for lung cancer. PMID: 27511159 
• Ng T, Teo SM, Yeo HL, Shwe M, Gan YX, Cheung YT, Foo KM, Cham MT, Lee JA, Tan YP, Fan G, Yong WS, Preetha M, Loh WJ, Koo SL, Jain A, Lee GE, Wong M, Dent R, Yap YS, Ng R, Khor CC, Ho HK, Chan A. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer. Neuro Oncol. 2016 Feb;18(2):244-51. doi: 10.1093/neuonc/nov162. Epub 2015 Aug 19. JIF: 3.07 PMID: 26289590 
• Jain A, Lim C, Gan EM, Ng DZ, Ng QS, Ang MK, Takano A, Chan KS, Tan WM, Kanesvaran R, Toh CK, Loo CM, Hsu AA, Devanand A, Lim CH, Koong HN, Koh T, Fong KW, Yap SP, Kim SW, Chowbay B, Oon L, Lim KH, Lim WT, Tan EH, Tan DS. Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. PLoS One. 2015 May 8;10(5):e0123587. doi: 10.1371/journal.pone.0123587. eCollection 2015. JIF: 3.234 PMID: 25955322 
• Jain A, Tan TJ, Tan DS. Carcinoma of unknown primary site. N Engl J Med. 2014 Nov 20;371(21):2039. JIF:53.29 PMID: 25409387 Influence of smoking status on response to EGFR TKI – A retrospective analysis of reflex EGFR mutation testing in Asian patients with Advanced Lung Adenocarcinomas, Jain et al, Annals of Oncology, Volume 23 suppl 9 September 2012. 
• Jain A, Liew N, Chia WK, Chew SH, Chia YN, Lim TH, Lim A, Lim SL, Wong CF, Toh KL, Tan MH. (2011) Coexisting metastatic choriocarcinoma and bladder adenocarcinoma of common germ cell origin. Ann Acad Med Singapore. 2011 Dec;40(12):548-9. JIF: 1.362 PMID: 22294067 
• Puvanendran K, Venkatramani J, Jain A, Farid M. Sleep deprivation in Junior Doctors - House Officers in Singapore. Ind Health. 2005;43(1):129-32.